Open for inclusion

A first-in-human Phase 1 dose excalation study of SAR428926 in patients with advanced solid tumors

Cancer type: Solide tumores

Phase: I

Principal Investigator: Lassen Ulrik

Country: DK

Keywords: Denmark, Rigshospitalet, LAMP-ADC

Status: Open for inclusion